Pioneer Drugs: The Path to FDA Approval

Pioneer drugs are the original, FDA-approved animal health products brought to market through the New Animal Drug Application (NADA) process. This regulatory pathway is designed to ensure a medication is safe, effective, and manufactured consistently.

To obtain FDA approval, the drug sponsor must conduct dose determination studies, target animal safety studies in horses, clinical and field efficacy trials, and environmental assessments. They must also demonstrate strict chemistry and manufacturing controls. This information is submitted to the FDA Center for Veterinary Medicine for review.

The NADA approval process typically takes five to 10 years, depending on the complexity of the drug and the condition being treated. This extensive review process helps establish confidence in pioneer products.

Generics: Same Safety and Efficacy, Lower Price

Generic animal drugs enter the market through the Abbreviated New Animal Drug Application (ANADA) process after an approved pioneer drug’s patent expires. Generic manufacturers must demonstrate bioequivalence to the pioneer product.

Bioequivalence means the generic contains the same active ingredient, works the same way at the same dose and route of administration, and has the same safety and efficacy profile as the pioneer drug. Depending on the product, this may be demonstrated through laboratory testing or animal trials.

Although the application process is abbreviated, generic drugs are held to the same FDA manufacturing standards as pioneer drugs. Once approved, generics stand on their own in the marketplace and can be sold even if the pioneer product is discontinued.

Compounded Drugs: Filling a Need

Pharmacy-compounded drugs are not reviewed or approved by the FDA. As a result, they do not undergo the same level of testing for safety, efficacy, or manufacturing consistency as FDA-approved products.

Compounding can play a legitimate role when no approved drug exists for a specific condition or when an approved formulation is not suitable for a particular horse. Compounding pharmacies may alter an active ingredient or an approved drug to create a different concentration or dosage form.

Because compounded products are not subject to FDA review, your veterinarian should carefully consider the circumstances in which they are used and evaluate a pharmacy’s quality controls and recordkeeping when recommending them.

Concerns Over Counterfeit Drugs

Counterfeit drugs are a growing concern in equine medicine. These products are designed to look like FDA-approved drugs but may contain unknown ingredients that are untested, unsafe, or ineffective. Counterfeit products are most commonly sold through online retailers rather than established veterinary distribution channels.

Warning signs may include misspelled labels, missing lot numbers or expiration dates, poor print quality, or inconsistent packaging. Some counterfeit products may replicate legitimate contact information, making identification more challenging.

If you suspect a product may be counterfeit, contact your veterinarian before using it. Your veterinarian can help report the product to the supplier or the FDA.

Take-Home Message

FDA-approved pioneer and generic drugs have undergone rigorous review to ensure safety, quality, and efficacy in horses. Compounded medications do not undergo the same approval process but may be appropriate in specific situations. Talk to your veterinarian about these drug categories to better understand which option makes sense for your horse.